AAAAAA

   
Results: 1-14 |
Results: 14

Authors: BARRINGTON RE SUBLER MA RANDS E OMER CA MILLER PJ HUNDLEY JE KOESTER SK TROYER DA BEARSS DJ CONNER MW GIBBS JB HAMILTON K KOBLAN KS MOSSER SD ONEILL TJ SCHABER MD SENDERAK ET WINDLE JJ OLIFF A KOHL NE
Citation: Re. Barrington et al., A FARNESYLTRANSFERASE INHIBITOR INDUCES TUMOR-REGRESSION IN TRANSGENIC MICE HARBORING MULTIPLE ONCOGENIC MUTATIONS BY MEDIATING ALTERATIONSIN BOTH CELL-CYCLE CONTROL AND APOPTOSIS, Molecular and cellular biology, 18(1), 1998, pp. 85-92

Authors: KOESTER SK SCHLOSSMAN SE ZHANG CH DECKER SJ BOLTON WE
Citation: Sk. Koester et al., APO2.7 DEFINES A SHARED APOPTOTIC-NECROTIC PATHWAY IN A BREAST-TUMOR HYPOXIA MODEL, Cytometry, 33(3), 1998, pp. 324-332

Authors: HUNDLEY JE KOESTER SK TROYER DA HILSENBECK SG SUBLER MA WINDLE JJ
Citation: Je. Hundley et al., INCREASED TUMOR PROLIFERATION AND GENOMIC INSTABILITY WITHOUT DECREASED APOPTOSIS IN MMTV-RAS MICE DEFICIENT IN P53, Molecular and cellular biology, 17(2), 1997, pp. 723-731

Authors: KOESTER SK ROTH P MIKULKA WR SCHLOSSMAN SF ZHANG CH BOLTON WE
Citation: Sk. Koester et al., MONITORING EARLY CELLULAR-RESPONSES IN APOPTOSIS IS AIDED BY THE MITOCHONDRIAL-MEMBRANE PROTEIN-SPECIFIC MONOCLONAL-ANTIBODY APO2.7, Cytometry, 29(4), 1997, pp. 306-312

Authors: OBRIEN MC HEALY SF RANEY SR HURST JM AVNER B HANLY A MIES C FREEMAN JW SNOW C KOESTER SK BOLTON WE
Citation: Mc. Obrien et al., DISCRIMINATION OF LATE APOPTOTIC NECROTIC CELLS (TYPE-III) BY FLOW-CYTOMETRY IN SOLID TUMORS/, Cytometry, 28(1), 1997, pp. 81-89

Authors: HUNDLEY JE KOESTER SK TROYER DA HILSENBECK SG BARRINGTON RE WINDLE JJ
Citation: Je. Hundley et al., DIFFERENTIAL REGULATION OF CELL-CYCLE CHARACTERISTICS AND APOPTOSIS IN MMTV-MYC AND MMTV-RAS MOUSE MAMMARY-TUMORS, Cancer research, 57(4), 1997, pp. 600-603

Authors: WOYNAROWSKI JM NAPIER C KOESTER SK CHEN SF TROYER D CHAPMAN W MACDONALD JR
Citation: Jm. Woynarowski et al., EFFECTS ON DNA INTEGRITY AND APOPTOSIS INDUCTION BY A NOVEL ANTITUMORSESQUITERPENE DRUG, 6-HYDROXYMETHYLACYLFULVENE (HMAF, MGI-114), Biochemical pharmacology, 54(11), 1997, pp. 1181-1193

Authors: BOOTH RE KOESTER SK
Citation: Re. Booth et Sk. Koester, ISSUES AND APPROACHES TO EVALUATING HIV OUTREACH INTERVENTIONS, Journal of drug issues, 26(3), 1996, pp. 525-539

Authors: BOOTH RE KOESTER SK PINTO F
Citation: Re. Booth et al., GENDER DIFFERENCES IN SEX-RISK BEHAVIORS, ECONOMIC LIVELIHOOD, AND SELF-CONCEPT AMONG DRUG INJECTORS AND CRACK SMOKERS, The American journal on addictions, 4(4), 1995, pp. 313-322

Authors: KOESTER SK MAENPAA JU WIEBE VJ BAKER WJ WURZ GT SEYMOUR RC KOEHLER RE DEGREGORIO MW
Citation: Sk. Koester et al., FLOW-CYTOMETRY - POTENTIAL UTILITY IN MONITORING DRUG EFFECTS IN BREAST-CANCER, Breast cancer research and treatment, 32(1), 1994, pp. 57-65

Authors: KOESTER SK
Citation: Sk. Koester, COPPING, RUNNING, AND PARAPHERNALIA LAWS - CONTEXTUAL VARIABLES AND NEEDLE RISK BEHAVIOR AMONG INJECTION-DRUG USERS IN DENVER, Human organization, 53(3), 1994, pp. 286-295

Authors: BAKER WJ MAENPAA JU WURZ GT KOESTER SK SEYMOUR RC EMSHOFF VD WIEBE VJ DEGREGORIO MW
Citation: Wj. Baker et al., TOREMIFENE ENHANCES CELL-CYCLE BLOCK AND GROWTH-INHIBITION BY VINBLASTINE IN MULTIDRUG-RESISTANT HUMAN BREAST-CANCER CELLS, Oncology research, 5(6-7), 1993, pp. 207-212

Authors: MAENPAA JU WURZ GT BAKER WJ WIEBE VJ EMSHOFF VD KOESTER SK SEYMOUR RC KOEHLER RE DEGREGORIO MW
Citation: Ju. Maenpaa et al., A BREAST-CANCER CLONE SELECTED BY TAMOXIFEN HAS INCREASED GROWTH-RATEAND REDUCED SENSITIVITY TO DOXORUBICIN, Oncology research, 5(12), 1993, pp. 461-466

Authors: SIPILA PEH WIEBE VJ HUBBARD GB KOESTER SK EMSHOFF VD MAENPAA JU WURZ GT SEYMOUR RC DEGREGORIO MW
Citation: Peh. Sipila et al., PROLONGED TAMOXIFEN EXPOSURE SELECTS A BREAST-CANCER CELL CLONE THAT IS STABLE IN-VITRO AND IN-VIVO, European journal of cancer, 29A(15), 1993, pp. 2138-2144
Risultati: 1-14 |